PDF herunterladen
Kardiologie up2date 2022; 18(04): 314-319
DOI: 10.1055/a-1949-5464
SOP

SOP Vakzininduzierte immunogene thrombotische Thrombozytopenie

Thomas Thiele
,
Albrecht Günther
,
Linda Schoenborn
,
Florian Langer
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für perioperativ und intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.

Publikationsverlauf

Artikel online veröffentlicht:
06. Dezember 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Greinacher A, Thiele T, Warkentin TE. et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med 2021; 384: 2092-2101
    Suche in Google Scholar
  • 2 Pavord S, Scully M, Hunt BJ. et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021; 385: 1680-1689
    Suche in Google Scholar
  • 3 Perry RJ, Tamborska A, Singh B. et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 2021; 398: 1147-1156
    CrossrefPubMedSuche in Google Scholar
  • 4 Schultz NH, Sorvoll IH, Michelsen AE. et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2124-2130
    CrossrefPubMedSuche in Google Scholar
  • 5 Scully M, Singh D, Lown R. et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2202-2211
    CrossrefPubMedSuche in Google Scholar
  • 6 Tiede A, Sachs UJ, Czwalinna A. et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccine. Blood 2021; 138: 350-353
    CrossrefPubMedSuche in Google Scholar
  • 7 Muir KL, Kallam A, Koepsell SA. et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med 2021; 384: 1964-1965
    CrossrefPubMedSuche in Google Scholar
  • 8 Huynh A, Kelton JG, Arnold DM. et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature 2021; 596: 565-569
    Suche in Google Scholar
  • 9 Greinacher A. Heparin-Induced Thrombocytopenia. N Engl J Med 2015; 373: 1883-1884
    CrossrefPubMedSuche in Google Scholar
  • 10 Salih F, Schonborn L, Kohler S. et al. Vaccine-Induced Thrombocytopenia with Severe Headache. N Engl J Med 2021; 385: 2103-2105
    CrossrefPubMedSuche in Google Scholar
  • 11 Greinacher A, Langer F, Makris M. et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources. J Thromb Haemost 2022; 20: 149-156
    Suche in Google Scholar
  • 12 Vayne C, Rollin J, Gruel Y. et al. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 376-378
    Suche in Google Scholar
  • 13 Platton S, Bartlett A, MacCallum P. et al. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 2021; 19: 2007-2013
    CrossrefPubMedSuche in Google Scholar
  • 14 Sachs UJ, Cooper N, Czwalinna A. et al. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison. Thromb Haemost 2021; 121: 1622-1627
    Suche in Google Scholar
  • 15 Thiele T, Weisser K, Schonborn L. et al. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Lancet Reg Health Eur 2022; 12: 100270
    CrossrefPubMedSuche in Google Scholar
  • 16 Graf T, Thiele T, Klingebiel R. et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021; 268: 4483-4485
    CrossrefPubMedSuche in Google Scholar
  • 17 Oldenburg J, Klamroth R, Langer F. et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. Hamostaseologie 2021; 41: 184-189
    Suche in Google Scholar
  • 18 Bourguignon A, Arnold DM, Warkentin TE. et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 720-728
    CrossrefPubMedSuche in Google Scholar
  • 19 Gunther A, Bramer D, Pletz MW. et al. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report. Vaccines (Basel) 2021; 9: 1344
    CrossrefPubMedSuche in Google Scholar
  • 20 Gessler F, Schmitz AK, Dubinski D. et al. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT. J Clin Med 2021; 10: 2777
    CrossrefPubMedSuche in Google Scholar
  • 21 Bundesärztekammer. Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2020. Zugriff am 05. Januar 2022 unter: https://www.bundesaerztekammer.de/aerzte/medizin-ethik/wissenschaftlicher-beirat/veroeffentlichungen/haemotherapietransfusionsmedizin/querschnitt-leitlinie/
    PubMed
  • 22 Patriquin CJ, Laroche V, Selby R. et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 857-859
    CrossrefPubMedSuche in Google Scholar
  • 23 Schonborn L, Thiele T, Kaderali L. et al. Decline in Pathogenic Antibodies over Time in VITT. N Engl J Med 2021; 385: 1815-1816
    CrossrefPubMedSuche in Google Scholar